Your trusted destination for CME, CPD & Medical Education across the Middle East.
The 2nd International Scientific Conference of the Hematology Department, Medical Research Institute, Alexandria University provides an educational platform for healthcare professionals to explore current advances in hematology and related specialties. The meeting combines scientific presentations, expert discussions, and research-focused exchange to promote knowledge sharing and strengthen contemporary approaches to the diagnosis and treatment of hematological diseases.
The 2nd International Scientific Conference of the Hematology Department, Medical Research Institute, Alexandria University is a specialized scientific meeting dedicated to advancing knowledge and clinical practice in hematology. The conference brings together hematologists, oncologists, researchers, laboratory specialists, and other healthcare professionals to discuss developments in the diagnosis and management of hematological disorders. Scientific sessions explore contemporary approaches to hematological malignancies, benign blood disorders, coagulation abnormalities, and emerging treatment strategies. Participants can examine recent clinical evidence, innovative diagnostic techniques, and evolving therapeutic options relevant to modern hematology practice. The conference also provides a platform for experts and researchers to exchange experiences, discuss challenging clinical cases, and explore opportunities for academic collaboration. Interactive presentations and scientific discussions are designed to encourage continuous learning and professional development. By highlighting advances in hematology research and patient care, the meeting aims to support evidence-based practice and improve outcomes for patients with blood disorders.
Exploring novel targeted therapies, immunotherapies, and treatment protocols for acute and chronic leukemias.
Current guidelines and emerging treatments for Hodgkin lymphoma, non-Hodgkin lymphoma, and multiple myeloma.
Latest approaches to the diagnosis and management of Sickle Cell Disease and Thalassemia.
Diagnostic challenges and therapeutic strategies for nutritional, aplastic, and hemolytic anemias.
Comprehensive management of hemophilia, von Willebrand disease, and other rare bleeding disorders.
Updates on the use of direct oral anticoagulants (DOACs) and the management of complex thrombotic events.
Recent advancements and clinical outcomes in autologous and allogeneic hematopoietic stem cell transplants.
Ensuring safety, efficacy, and best practices in modern blood transfusion and component therapy.
Indications, conditioning, complications and post-transplant management.
Flow cytometry, molecular testing, cytogenetics and other diagnostic techniques.
Applying molecular information to individualized hematologic treatment.
Monoclonal antibodies and other immune-directed approaches.
Secure your seat and earn full credit eligibility with encrypted checkout.
Secure payment processing & PCI-aligned flow